Načítá se...
Management of antipsychotic-induced hyperprolactinemia
INTRODUCTION: Antipsychotics represent a large portion of the psychotropics that may induce hyperprolactinemia. Clinical psychiatric pharmacists must be adept in stratifying the relative risk of hyperprolactinemia among psychotropics, identifying patient risk factors, recognizing differential diagno...
Uloženo v:
| Vydáno v: | Ment Health Clin |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
College of Psychiatric & Neurologic Pharmacists
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6007722/ https://ncbi.nlm.nih.gov/pubmed/29955468 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2016.07.185 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|